<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Res Protoc</journal-id><journal-id journal-id-type="iso-abbrev">JMIR Res Protoc</journal-id><journal-id journal-id-type="publisher-id">ResProt</journal-id><journal-title-group><journal-title>JMIR Research Protocols</journal-title></journal-title-group><issn pub-type="epub">1929-0748</issn><publisher><publisher-name>JMIR Publications Inc.</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25986784</article-id><article-id pub-id-type="pmc">4451261</article-id><article-id pub-id-type="publisher-id">v4i2e56</article-id><article-id pub-id-type="doi">10.2196/resprot.4138</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group><subj-group subj-group-type="article-type"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Contribution of Transcranial Direct Current Stimulation on Inhibitory Control to Assess the Neurobiological Aspects of Attention Deficit Hyperactivity Disorder: Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Eysenbach</surname><given-names>Gunther</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>McCabe</surname><given-names>Kathryn</given-names></name></contrib></contrib-group><contrib-group><contrib id="contrib1" contrib-type="author" corresp="yes"><name><surname>Cosmo</surname><given-names>Camila</given-names></name><degrees>MD, MSc, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><address><institution>Spaulding Neuromodulation Center</institution><institution>Department of Physical Medicine and Rehabilitation</institution><institution>Spaulding Rehabilitation Hospital/ Harvard Medical School</institution><addr-line>79/96 13th St</addr-line><addr-line>Charlestown, MA, 02129</addr-line><country>United States</country><phone>1 617 952 6164</phone><fax>1 617 952 6060</fax><email>ccosmo@ufba.br</email></address><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5874-7188</contrib-id></contrib><contrib id="contrib2" contrib-type="author"><name><surname>Baptista</surname><given-names>Abrah&#x000e3;o Fontes</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7870-3820</contrib-id></contrib><contrib id="contrib3" contrib-type="author"><name><surname>de Sena</surname><given-names>Eduardo Pond&#x000e9;</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6166-8093</contrib-id></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Spaulding Neuromodulation Center</institution><institution>Department of Physical Medicine and Rehabilitation</institution><institution>Spaulding Rehabilitation Hospital/ Harvard Medical School</institution><addr-line>Charlestown, MA</addr-line><country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>PostGraduate Program - Interactive Process of Organs and Systems</institution><institution>Health Sciences Institute</institution><institution>Federal University of Bahia</institution><addr-line>Salvador</addr-line><country>Brazil</country></aff><aff id="aff3"><sup>3</sup><institution>Functional Electrostimulation Laboratory</institution><institution>Biomorphology Department</institution><institution>Federal University of Bahia</institution><addr-line>Salvador</addr-line><country>Brazil</country></aff><aff id="aff4"><sup>4</sup><institution>Specialized Support Network Coordination</institution><institution>Department of Health (SESAB)</institution><institution>Bahia State Government</institution><addr-line>Salvador</addr-line><country>Brazil</country></aff><aff id="aff5"><sup>5</sup><institution>PostGraduate Program on Medicine and Human Health,</institution><institution>Faculty of Medicine</institution><institution>Federal University of Bahia</institution><addr-line>Salvador</addr-line><country>Brazil</country></aff><author-notes><corresp>Corresponding Author: Camila Cosmo <email>ccosmo@ufba.br</email></corresp></author-notes><pub-date pub-type="collection"><season>Apr-Jun</season><year>2015</year></pub-date><pub-date pub-type="epub"><day>18</day><month>5</month><year>2015</year></pub-date><volume>4</volume><issue>2</issue><elocation-id>e56</elocation-id><history><date date-type="received"><day>13</day><month>12</month><year>2014</year></date><date date-type="rev-request"><day>17</day><month>2</month><year>2015</year></date><date date-type="rev-recd"><day>09</day><month>4</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9;Camila Cosmo, Abrah&#x000e3;o Fontes Baptista, Eduardo Pond&#x000e9; de Sena. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 18.05.2015. </copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p><!--CREATIVE COMMONS-->This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0/">http://creativecommons.org/licenses/by/2.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="http://www.researchprotocols.org,">http://www.researchprotocols.org,</ext-link> as well as this copyright and license information must be included.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="http://www.researchprotocols.org/2015/2/e56/"/><abstract><sec sec-type="background"><title>Background</title><p>The applicability of transcranial direct current stimulation (tDCS) in individuals with attention deficit hyperactivity disorder (ADHD) has not yet been investigated. This low-cost, non-invasive, and safe technique optimized to modulate the inhibitory response might be a useful treatment option for those affected by this condition.</p></sec><sec sec-type="objective"><title>Objective</title><p>The aim of this single center, parallel, randomized, double-blinded, sham-controlled trial is to investigate the efficacy of transcranial direct current stimulation over the prefrontal cortex on the modulation of inhibitory control in adults with attention deficit hyperactivity disorder.</p></sec><sec sec-type="methods"><title>Methods</title><p>A total of 60 individuals will be divided into 2 groups by block randomization to receive active or sham stimulation. Anodal stimulation over the left dorsolateral prefrontal cortex will be applied at 1 mA during a single 20-minute session. Before and after interventions, subjects will perform 2 go/no go tasks and the brain electrical activity will be recorded by electroencephalogram (EEG) with 32 channels, according to the 10-20 international EEG system.</p></sec><sec sec-type="results"><title>Results</title><p>The trial began in May 2013 and we are currently performing the statistical analysis for the secondary outcomes.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>The findings from this study will provide preliminary results about the role of prefrontal cortex activation through tDCS on ADHD patients.</p></sec><sec><title>Trial Registration</title><p>Clinicaltrials.gov NCT01968512; http://clinicaltrials.gov/ct2/show/NCT01968512 (Archived by WebCite at www.webcitation.org/6YMSW2tkD).</p></sec></abstract><kwd-group><kwd>Attention deficit hyperactivity disorder</kwd><kwd>inhibitory control</kwd><kwd>transcranial direct current stimulation</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction"><title>Introduction</title><p>Attention deficit hyperactivity disorder (ADHD) presents prevalence rates in US studies of 5%-9% in childhood, especially in school age children. Of those affected, 67% continue to present symptoms in adulthood, which may compromise psychosocial, professional, and emotional development [<xref rid="ref1" ref-type="bibr">1</xref>-<xref rid="ref5" ref-type="bibr">5</xref>]. In a recent study, Arruda et al observed a prevalence rate of ADHD among children and adolescents of 4.4% [<xref rid="ref6" ref-type="bibr">6</xref>]. However, despite the significant social impact, some of these patients remain undiagnosed and therefore without proper therapeutic intervention. The diagnosis, based on clinical assessment and identification of symptoms established by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), involves inattention, hyperactivity, impulsivity, and general criteria [<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref8" ref-type="bibr">8</xref>].</p><p>The clinical presentation of ADHD may arise from disorders in the prefrontal cortex and its subcortical connections [<xref rid="ref8" ref-type="bibr">8</xref>-<xref rid="ref11" ref-type="bibr">11</xref>]. This assumption is supported by the hypothesis that it is a neurobiological disorder, evidenced by functional deficits in neurotransmitters such as dopamine and norepinephrine, and by disorders in the frontal lobe. These disorders trigger the symptoms observed in ADHD patients including impulsivity, difficulty in inhibiting distracting behaviors, and difficulty in planning and executing tasks under focused attention and concentration [<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref12" ref-type="bibr">12</xref>]. Together, these symptoms reveal the impairment of important executive functions in individuals with ADHD [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref13" ref-type="bibr">13</xref>].</p><p>There is evidence of a physiological association between the prefrontal cortex and inhibitory control [<xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref14" ref-type="bibr">14</xref>], whereby changes in this anatomical structure may account for impairments in inhibitory control. Indeed, behavior-based actions that reflect inconsequence, unpredictability, intolerance to waiting, quick and inconsistent responses, possible exposure to hazards, and acceptance of multiple responsibilities and tasks simultaneously with consequently further withdrawals support this idea [<xref rid="ref9" ref-type="bibr">9</xref>].This anatomical relationship between prefrontal cortex and inhibitory behavior, together with an understanding of the neurobiological mechanisms comprise a physiological framework that supports the hypothesis that activation of the prefrontal area will result in a larger and more suitable inhibitory control, minimizing the socioaffective consequences associated with this condition.</p><p>Transcranial direct current stimulation (tDCS) is a simple and well-known neuromodulatory technique [<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref16" ref-type="bibr">16</xref>] which involves applying low voltage electrical currents to increase or decrease neuronal excitability of the stimulated area [<xref rid="ref16" ref-type="bibr">16</xref>,<xref rid="ref17" ref-type="bibr">17</xref>]. tDCS is a noninvasive and safe approach, characterized by infrequent and mild adverse effects including local discomfort, itching, paresthesia, and/or short-lasting headaches [<xref rid="ref17" ref-type="bibr">17</xref>].</p><p>The aim of this trial is to investigate the efficacy of tDCS over the prefrontal cortex on the modulation of inhibitory control in adults with ADHD by assessing behavioral and neurophysiological parameters. We expect that the application of this low-cost and safe technique will increase the inhibitory response in ADHD individuals what may result in a greater ability to inhibit inappropriate behaviors.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study Design</title><p>This is a single-center, parallel, randomized, double-blinded, sham-controlled trial, conducted in the Laboratory of Functional Electrostimulation at the Federal University of Bahia (Salvador, Brazil). This study will include descriptive and analytical steps designed to investigate the neurobiological aspects of patients with ADHD, and the response of inhibitory control parameters to tDCS.</p></sec><sec><title>Population</title><p>Patients with ADHD will be recruited by sending letters and emails to neuropsychiatric societies and associations. Professional experts in ADHD, contacted by mail and telephone, will be invited to refer potential patients for the study. Advertisements will be published on the Internet and social networking sites, according to the inclusion criteria.</p></sec><sec><title>Inclusion Criteria</title><p>The inclusion criteria for the study are (1) the ability to understand and sign the informed consent form, (2) a diagnosis of ADHD according to DSM-IV-TR and the Adult Self-Report Scale (ASRS), (3) resident of Bahia, and (4) &#x02265;18 years old.</p></sec><sec><title>Exclusion Criteria</title><p>Patients who meet the following criteria will be excluded (1) major psychiatric disorders such as schizophrenia and bipolar disorder, (2) inability to understand the questionnaires applied (cognitive impairment score of &#x02264;24 on the Mini-Mental State Examination) or illiterate, and (3) abuse of psychoactive substances or alcohol, except nicotine and caffeine, during the last 12 months.</p></sec><sec><title>Sample Size</title><p>A sample size of 50 subjects was calculated assuming a difference in proportion between the active tDCS and sham control groups of 40% on the go/no go performance, before and after interventions. This calculation was performed using the statistical program STATA 12.0, considering an alpha of .05 and a power of 0.80, resulting in a sample of 25 subjects in each group (intervention and control). To address unexpected factors, we applied a dropout rate of 20%, reaching a total sample size of 60 individuals.</p></sec><sec><title>Randomization and Blinding</title><p>Individuals will be divided into two groups by block randomization aiming for a balanced distribution between the groups (30 subjects each), and considering gender and age as variables. Blocks will be composed of 10 subjects, totaling 6 blocks. Each intervention group will comprise 5 individuals from each block.</p><p>An external researcher will perform the randomization and will generate a list to allocate patients and ensure a concealed allocation.</p><p>Excluding the external researcher, investigators applying the go/no go tasks and registering the EEG, and the subjects will be blind to the intervention. Raters and researchers responsible for the statistical analysis will not be aware of the treatment group that the patient will be enrolled. For analysis purposes, the intervention groups will be identified as &#x0201c;0&#x0201d; and &#x0201c;1&#x0201d;. Blinding code will be known only by the principal investigator and by the person responsible for the stimulation.</p></sec><sec><title>Ethical Aspects</title><p>In accordance with the Declaration of Helsinki [<xref rid="ref18" ref-type="bibr">18</xref>], this study strictly follows the ethical principles in research involving human subjects. All participants will be informed about the nature of the study and all procedures prior to enrollment. Following the resolution 196/96 of the National Health Council (Brazil), only those that will sign the informed consent form will be included. The signature of a witness will be required for the patients unable to sign the free and informed consent form.</p><p>This trial was approved on October 2012 (IRB approval number 19311) by the institutional review board of the Maternidade Clim&#x000e9;rio de Oliveira-Federal University of Bahia.</p></sec><sec><title>Consent Procedures</title><p>Signed consent will be obtained from each participant. Only subjects capable of understanding and agreeing to the consent will be enrolled. In addition to a signed consent form and prior to any intervention, participants will receive a detailed explanation about the trial aims and procedures that will be performed. Two experienced researchers will explain that participation is voluntary and they may withdraw at anytime without losses. The trial staff also will be available to clarify any question; at the same time they will assure that subjects understood all of the steps of the study. Participants will have an indefinite amount of time to make a decision, and those that agree, will be asked to sign two copies of the informed consent form.</p></sec><sec><title>Assessments</title><p>Following the consent procedures, subjects will undergo a cognitive screening using the MiniMental State Examination (MMSE) [<xref rid="ref19" ref-type="bibr">19</xref>,<xref rid="ref20" ref-type="bibr">20</xref>], the Mini International Neuropsychiatric Interview Brazilian (MINI PLUS) [<xref rid="ref21" ref-type="bibr">21</xref>], the Adult Self-Report Scale (ASRS) [<xref rid="ref22" ref-type="bibr">22</xref>], the Adult ADHD Quality of Life Questionnaire (AAQoL), and an interview with a questionnaire. This evaluation script is an instrument based on the ADHD diagnostic criteria from DSM-IV-TR [<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref8" ref-type="bibr">8</xref>], and consists of epidemiological and clinical questions.</p><p>Posterior electrical brain activity will be recorded by EEG with 32 channels placed on the scalp, according to the 10-20 international EEG system. Each recording will last 5 minutes and will be performed in a resting state, with the patient's eyes open and looking for a fixed point during the first minute, and with closed eyes for the remaining four. Participants will then be asked to perform tasks on the computer: 2 go/no go tasks adapted from the original version using a fruit and a letter as the first and second target, respectively. Following the cognitive tasks, subjects will undergo the active or sham stimulation, according to the previous randomization. At the end of the intervention, subjects will perform the 2 go/no go tasks again (randomly selected to avoid learning effect), and they will undergo another EEG recording.</p><p>There will be no follow-up visits; participants will undergo a single visit of approximately two hours in duration. All subjects will be asked to abstain from caffeine, alcohol, and nicotine one day before the experiments.</p></sec><sec><title>Interventions</title><p>Participants of the intervention group will have the tDCS applied at 1 mA, with the anode electrode over the left dorsolateral prefrontal cortex and cathode electrode over the equivalent area on the right side. For the control group subjects, electrodes will be placed at identical positions and sham stimulation will be applied. The stimulation device will be turned on for 30 seconds so that the patient will feel the initial sensation, then will be shut down. The intervention and sham procedure will take place in one single 20-minute session to evaluate the immediate effect.</p><p>The application of tDCS and the assessment of its effects will be performed by clinical observation using a reduction of symptomatology as evaluated by the neuropsychological task, go/no go, and by neurophysiological assessment, measured by quantitative electroencephalogram (qEEG) and the
reconstruction of brain networks, as parameters.</p></sec><sec><title>Outcome Variables</title><p>The primary outcome of this trial is the inhibitory response measured as behavioral performance by two go/no go tasks. These tests are adapted from a previous version [<xref rid="ref23" ref-type="bibr">23</xref>], and will present as targets a fruit (version 1) and a letter (version 2). Participants will be asked to react when a target ("go" stimulus), and not when a non-target ("no go" stimulus) is presented. All stimuli will be presented in black and white ink with equal dimensions. In both versions of the go/no go tasks, one selected letter or fruit will be previously defined as the "go" stimulus and subjects will be instructed to press the left button of a computer mouse with the right finger as soon as this target is presented on the screen. Stimuli will be presented one-by-one on the computer screen during 650 milliseconds with 1000 millisecond interstimulus intervals (ISI). In each version of the task, 150 trials consisting of 80% "go" and 20% "no go" will be presented. Correct responses, impulsivity, and omissions errors will be computed separately for each version of the go/no go task, and will be the primary outcome variables.</p><p>The secondary outcome variables are power analysis of frequency bands through qEEG and the brain networks. For the EEG, data will be recorded from the 32 channels and a reference electrode (Cz) placed according to the 10-20 international EEG system with additional electrodes (FC3, FC4, CP3, CP4, FT7, FT8, TP7, TP8, and Oz). The EEG data will be filtered between 0.5-50 Hz, and analyzed through EEGLAB (The Mathworks, Inc.). Brain network reconstructions will be performed based on the EEG data.</p></sec><sec><title>Statistical Analysis</title><p>A 5-step statistical analysis will be conducted (see <xref ref-type="boxed-text" rid="box1">Textbox 1</xref>). These analyses will be performed using Stata, version 13.0 for Windows. Results will be considered statistically significant if <italic>P</italic>&#x0003c;.05.</p><boxed-text id="box1" position="float"><caption><title>The 5-step statistical analysis.</title></caption><p>Steps</p><list list-type="order"><list-item><p>The socio-demographic, clinical, and epidemiological description of the groups, using the usual procedures of descriptive statistics such as calculation of frequencies, measures of central tendency, and dispersion;</p></list-item><list-item><p>Characteristics will be compared between groups at baseline, using a one-way analysis of variance (ANOVA) for continuous variables and a chi-square test for categorical variables;</p></list-item><list-item><p>Shapiro-Wilk test will be performed to assess the normality assumption of the outcome variables;</p></list-item><list-item><p>Analysis of paired and independent samples using a <italic>t</italic> test for comparisons within each group and between intervention groups, or applying equivalent non-parametric tests (according to Shapiro-Wilk test results) before and after intervention;</p></list-item><list-item><p>Pearson chi-square test to evaluate blinding effectiveness, comparing between groups.</p></list-item></list></boxed-text></sec></sec><sec sec-type="results"><title>Results</title><p>This trial and enrollment began in May, 2013. The statistical analysis for the secondary outcomes is currently being performed.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The findings from this trial will provide preliminary results about the role of prefrontal cortex activation through tDCS on ADHD patients. The results of this clinical trial will allow us to evaluate behavioral and neurobiological aspects of ADHD in addition to observing the socio-demographical and clinical-epidemiological parameters of this population.</p><p>We will examine the tDCS contribution in modulating inhibitory control and neurophysiological parameters measured by neurocognitive tasks (go/no go), qEEG, and brain reconstruction network models. We also expect that the present trial will contribute scientifically to the development of neurophysiological assessment methods of ADHD, and to the evaluation of the feasibility of this low cost, non-invasive, and safe technique for optimization of inhibitory responses in ADHD patients.</p><p>One possible limitation is that we will only apply a single session of tDCS. However, since, to the present moment, there are no previous studies regarding tDCS in ADHD subjects, we opted for a conservative protocol with only one session of tDCS delivered at 1 mA to ensure safe parameters.</p><p>To the best of our knowledge, this trial will be the first study to assess the cognitive and neurophysiological effects of tDCS on ADHD patients. In the long term, we expect that our results might reinforce comprehensive programs of intervention and multidisciplinary approaches in patients with ADHD.</p></sec></body><back><fn-group><fn fn-type="con"><p>Authors' Contributions: CC, AB, and EPS conceived and designed this protocol, and drafted and revised the manuscript.</p></fn><fn fn-type="conflict"><p>Conflicts of Interest: None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AAQoL</term><def><p>Adults with ADHD Quality of Life Questionnaire</p></def></def-item><def-item><term id="abb2">ADHD</term><def><p>Attention deficit hyperactivity disorder</p></def></def-item><def-item><term id="abb3">ASRS</term><def><p>Adult Self-Report Scale</p></def></def-item><def-item><term id="abb4">DSM-IV-TR</term><def><p>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision</p></def></def-item><def-item><term id="abb5">EEG</term><def><p>Electroencephalogram</p></def></def-item><def-item><term id="abb6">ICF</term><def><p>Informed consent form</p></def></def-item><def-item><term id="abb7">MINI-plus</term><def><p>Mini International Neuropsychiatric Interview Plus</p></def></def-item><def-item><term id="abb8">MMSE</term><def><p>Mini Mental State Examination</p></def></def-item><def-item><term id="abb9">qEEG</term><def><p>Quantitative electroencephalogram</p></def></def-item><def-item><term id="abb10">tDCS</term><def><p>Transcranial direct current stimulation</p></def></def-item></def-list></glossary><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundervold</surname><given-names>Astri J</given-names></name><name><surname>Adolfsdottir</surname><given-names>Steinunn</given-names></name><name><surname>Halleland</surname><given-names>Helene</given-names></name><name><surname>Halm&#x000f8;y</surname><given-names>Anne</given-names></name><name><surname>Plessen</surname><given-names>Kerstin</given-names></name><name><surname>Haavik</surname><given-names>Jan</given-names></name></person-group><article-title>Attention Network Test in adults with ADHD--the impact of affective fluctuations</article-title><source>Behav Brain Funct</source><year>2011</year><volume>7</volume><fpage>27</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.behavioralandbrainfunctions.com/content/7//27"/></comment><pub-id pub-id-type="doi">10.1186/1744-9081-7-27</pub-id><pub-id pub-id-type="medline">21794128</pub-id><!--<pub-id pub-id-type="pii">1744-9081-7-27</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC3168400</pub-id>--><pub-id pub-id-type="pmid">21794128</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranby</surname><given-names>Krista W</given-names></name><name><surname>Boynton</surname><given-names>Marcella H</given-names></name><name><surname>Kollins</surname><given-names>Scott H</given-names></name><name><surname>McClernon</surname><given-names>F Joseph</given-names></name><name><surname>Yang</surname><given-names>Chongming</given-names></name><name><surname>Fuemmeler</surname><given-names>Bernard F</given-names></name></person-group><article-title>Understanding the phenotypic structure of adult retrospective ADHD symptoms during childhood in the United States</article-title><source>J Clin Child Adolesc Psychol</source><year>2012</year><volume>41</volume><issue>3</issue><fpage>261</fpage><lpage>74</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/22394329"/></comment><pub-id pub-id-type="doi">10.1080/15374416.2012.654465</pub-id><pub-id pub-id-type="medline">22394329</pub-id><!--<pub-id pub-id-type="pmcid">PMC3354630</pub-id>--><pub-id pub-id-type="pmid">22394329</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biederman</surname><given-names>Joseph</given-names></name><name><surname>Petty</surname><given-names>Carter R</given-names></name><name><surname>Woodworth</surname><given-names>K Yvonne</given-names></name><name><surname>Lomedico</surname><given-names>Alexandra</given-names></name><name><surname>Hyder</surname><given-names>Laran L</given-names></name><name><surname>Faraone</surname><given-names>Stephen V</given-names></name></person-group><article-title>Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study</article-title><source>J Clin Psychiatry</source><year>2012</year><month>7</month><volume>73</volume><issue>7</issue><fpage>941</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.4088/JCP.11m07529</pub-id><pub-id pub-id-type="medline">22901345</pub-id><pub-id pub-id-type="pmid">22901345</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>T</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Wilens</surname><given-names>TE</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name></person-group><article-title>Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis</article-title><source>J Clin Psychiatry</source><year>1998</year><volume>59 Suppl 7</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="medline">9680054</pub-id><pub-id pub-id-type="pmid">9680054</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wender</surname><given-names>PH</given-names></name></person-group><article-title>Attention-deficit hyperactivity disorder in adults</article-title><source>Psychiatr Clin North Am</source><year>1998</year><month>12</month><volume>21</volume><issue>4</issue><fpage>761</fpage><lpage>74, v</lpage><pub-id pub-id-type="medline">9890120</pub-id><pub-id pub-id-type="pmid">9890120</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arruda</surname><given-names>Marco A</given-names></name><name><surname>Querido</surname><given-names>C&#x000ed;cero Nardini</given-names></name><name><surname>Bigal</surname><given-names>Marcelo E</given-names></name><name><surname>Polanczyk</surname><given-names>Guilherme V</given-names></name></person-group><article-title>ADHD and mental health status in Brazilian school-age children</article-title><source>J Atten Disord</source><year>2015</year><month>1</month><volume>19</volume><issue>1</issue><fpage>11</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1177/1087054712446811</pub-id><pub-id pub-id-type="medline">22665924</pub-id><!--<pub-id pub-id-type="pii">1087054712446811</pub-id>--><pub-id pub-id-type="pmid">22665924</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owens</surname><given-names>J</given-names></name><name><surname>Hoza</surname><given-names>B</given-names></name></person-group><article-title>Diagnostic utility of DSM-IV-TR symptoms in the prediction of DSM-IV-TR ADHD subtypes and ODD</article-title><source>J Atten Disord</source><year>2003</year><month>9</month><volume>7</volume><issue>1</issue><fpage>11</fpage><lpage>27; discussion 29</lpage><pub-id pub-id-type="medline">14738178</pub-id><pub-id pub-id-type="pmid">14738178</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>KW</given-names></name><name><surname>Reichl</surname><given-names>S</given-names></name><name><surname>Lange</surname><given-names>KM</given-names></name><name><surname>Tucha</surname><given-names>L</given-names></name><name><surname>Tucha</surname><given-names>O</given-names></name></person-group><article-title>The history of attention deficit hyperactivity disorder</article-title><source>Attention deficit and hyperactivity disorders</source><year>2010</year><pub-id pub-id-type="doi">10.1055/s-2007-1013610</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>Amy FT</given-names></name><name><surname>Li</surname><given-names>Bao-Ming</given-names></name></person-group><article-title>Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions</article-title><source>Biol Psychiatry</source><year>2005</year><month>6</month><day>1</day><volume>57</volume><issue>11</issue><fpage>1377</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2004.08.019</pub-id><pub-id pub-id-type="medline">15950011</pub-id><!--<pub-id pub-id-type="pii">S0006-3223(04)00933-3</pub-id>--><pub-id pub-id-type="pmid">15950011</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickstein</surname><given-names>Steven G</given-names></name><name><surname>Bannon</surname><given-names>Katie</given-names></name><name><surname>Castellanos</surname><given-names>F Xavier</given-names></name><name><surname>Milham</surname><given-names>Michael P</given-names></name></person-group><article-title>The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis</article-title><source>J Child Psychol Psychiatry</source><year>2006</year><month>10</month><volume>47</volume><issue>10</issue><fpage>1051</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7610.2006.01671.x</pub-id><pub-id pub-id-type="medline">17073984</pub-id><!--<pub-id pub-id-type="pii">JCPP1671</pub-id>--><pub-id pub-id-type="pmid">17073984</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubia</surname><given-names>Katya</given-names></name><name><surname>Alegr&#x000ed;a</surname><given-names>Analuc&#x000ed;a A</given-names></name><name><surname>Brinson</surname><given-names>Helen</given-names></name></person-group><article-title>Brain abnormalities in attention-deficit hyperactivity disorder: a review</article-title><source>Rev Neurol</source><year>2014</year><month>2</month><day>24</day><volume>58 Suppl 1</volume><fpage>S3</fpage><lpage>16</lpage><pub-id pub-id-type="medline">25252664</pub-id><!--<pub-id pub-id-type="pii">rn2013570</pub-id>--><pub-id pub-id-type="pmid">25252664</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>Nora D</given-names></name><name><surname>Swanson</surname><given-names>James M</given-names></name></person-group><article-title>Clinical practice: Adult attention deficit-hyperactivity disorder</article-title><source>N Engl J Med</source><year>2013</year><month>11</month><day>14</day><volume>369</volume><issue>20</issue><fpage>1935</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1056/NEJMcp1212625</pub-id><pub-id pub-id-type="medline">24224626</pub-id><pub-id pub-id-type="pmid">24224626</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haavik</surname><given-names>Jan</given-names></name><name><surname>Halm&#x000f8;y</surname><given-names>Anne</given-names></name><name><surname>Lundervold</surname><given-names>Astri J</given-names></name><name><surname>Fasmer</surname><given-names>Ole Bernt</given-names></name></person-group><article-title>Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder</article-title><source>Expert Rev Neurother</source><year>2010</year><month>10</month><volume>10</volume><issue>10</issue><fpage>1569</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1586/ern.10.149</pub-id><pub-id pub-id-type="medline">20925472</pub-id><pub-id pub-id-type="pmid">20925472</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>Linda</given-names></name><name><surname>Buckley</surname><given-names>Jack</given-names></name><name><surname>Gibbs</surname><given-names>David</given-names></name><name><surname>Kaplan</surname><given-names>Gary</given-names></name><name><surname>Lofton</surname><given-names>Kevin</given-names></name><name><surname>McDonagh</surname><given-names>Kathryn</given-names></name><name><surname>Schrader</surname><given-names>Ann</given-names></name><name><surname>Vaughn</surname><given-names>Anita</given-names></name><name><surname>Whetsell</surname><given-names>George</given-names></name><name><surname>Wade</surname><given-names>Richard</given-names></name></person-group><article-title>Executive dialogue series. Performance improvement in the era of quality improvement</article-title><source>Hosp Health Netw</source><year>2006</year><month>11</month><volume>80</volume><issue>11</issue><fpage>80</fpage><lpage>9</lpage><pub-id pub-id-type="medline">17216797</pub-id><pub-id pub-id-type="pmid">17216797</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunoni</surname><given-names>Andre Russowsky</given-names></name><name><surname>Nitsche</surname><given-names>Michael A</given-names></name><name><surname>Bolognini</surname><given-names>Nadia</given-names></name><name><surname>Bikson</surname><given-names>Marom</given-names></name><name><surname>Wagner</surname><given-names>Tim</given-names></name><name><surname>Merabet</surname><given-names>Lotfi</given-names></name><name><surname>Edwards</surname><given-names>Dylan J</given-names></name><name><surname>Valero-Cabre</surname><given-names>Antoni</given-names></name><name><surname>Rotenberg</surname><given-names>Alexander</given-names></name><name><surname>Pascual-Leone</surname><given-names>Alvaro</given-names></name><name><surname>Ferrucci</surname><given-names>Roberta</given-names></name><name><surname>Priori</surname><given-names>Alberto</given-names></name><name><surname>Boggio</surname><given-names>Paulo Sergio</given-names></name><name><surname>Fregni</surname><given-names>Felipe</given-names></name></person-group><article-title>Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions</article-title><source>Brain Stimul</source><year>2012</year><month>7</month><volume>5</volume><issue>3</issue><fpage>175</fpage><lpage>95</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/22037126"/></comment><pub-id pub-id-type="doi">10.1016/j.brs.2011.03.002</pub-id><pub-id pub-id-type="medline">22037126</pub-id><!--<pub-id pub-id-type="pii">S1935-861X(11)00026-X</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC3270156</pub-id>--><pub-id pub-id-type="pmid">22037126</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stagg</surname><given-names>Charlotte J</given-names></name><name><surname>Nitsche</surname><given-names>Michael A</given-names></name></person-group><article-title>Physiological basis of transcranial direct current stimulation</article-title><source>Neuroscientist</source><year>2011</year><month>2</month><volume>17</volume><issue>1</issue><fpage>37</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1177/1073858410386614</pub-id><pub-id pub-id-type="medline">21343407</pub-id><!--<pub-id pub-id-type="pii">17/1/37</pub-id>--><pub-id pub-id-type="pmid">21343407</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DaSilva</surname><given-names>Alexandre F</given-names></name><name><surname>Volz</surname><given-names>Magdalena Sarah</given-names></name><name><surname>Bikson</surname><given-names>Marom</given-names></name><name><surname>Fregni</surname><given-names>Felipe</given-names></name></person-group><article-title>Electrode positioning and montage in transcranial direct current stimulation</article-title><source>J Vis Exp</source><year>2011</year><issue>51</issue><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/21654618"/></comment><pub-id pub-id-type="doi">10.3791/2744</pub-id><pub-id pub-id-type="medline">21654618</pub-id><!--<pub-id pub-id-type="pii">2744</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC3339846</pub-id>--></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>Robert V</given-names></name><name><surname>Boyd</surname><given-names>Kenneth M</given-names></name><name><surname>Webb</surname><given-names>David J</given-names></name></person-group><article-title>The revision of the Declaration of Helsinki: past, present and future</article-title><source>Br J Clin Pharmacol</source><year>2004</year><month>6</month><volume>57</volume><issue>6</issue><fpage>695</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2004.02103.x</pub-id><pub-id pub-id-type="medline">15151515</pub-id><!--<pub-id pub-id-type="pii">BCP2103</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC1884510</pub-id>--><pub-id pub-id-type="pmid">15151515</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folstein</surname><given-names>MF</given-names></name><name><surname>Folstein</surname><given-names>SE</given-names></name><name><surname>McHugh</surname><given-names>PR</given-names></name></person-group><article-title>"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician</article-title><source>J Psychiatr Res</source><year>1975</year><month>11</month><volume>12</volume><issue>3</issue><fpage>189</fpage><lpage>98</lpage><pub-id pub-id-type="medline">1202204</pub-id><!--<pub-id pub-id-type="pii">0022-3956(75)90026-6</pub-id>--><pub-id pub-id-type="pmid">1202204</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolucci</surname><given-names>PH</given-names></name><name><surname>Brucki</surname><given-names>SM</given-names></name><name><surname>Campacci</surname><given-names>SR</given-names></name><name><surname>Juliano</surname><given-names>Y</given-names></name></person-group><article-title>[The Mini-Mental State Examination in a general population: impact of educational status]</article-title><source>Arq Neuropsiquiatr</source><year>1994</year><month>3</month><volume>52</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="medline">8002795</pub-id><pub-id pub-id-type="pmid">8002795</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>DV</given-names></name><name><surname>Lecrubier</surname><given-names>Y</given-names></name><name><surname>Sheehan</surname><given-names>KH</given-names></name><name><surname>Amorim</surname><given-names>P</given-names></name><name><surname>Janavs</surname><given-names>J</given-names></name><name><surname>Weiller</surname><given-names>E</given-names></name><name><surname>Hergueta</surname><given-names>T</given-names></name><name><surname>Baker</surname><given-names>R</given-names></name><name><surname>Dunbar</surname><given-names>GC</given-names></name></person-group><article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title><source>J Clin Psychiatry</source><year>1998</year><volume>59 Suppl 20</volume><fpage>22</fpage><lpage>33;quiz 34</lpage><pub-id pub-id-type="medline">9881538</pub-id><pub-id pub-id-type="pmid">9881538</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>Ronald C</given-names></name><name><surname>Adler</surname><given-names>Lenard</given-names></name><name><surname>Ames</surname><given-names>Minnie</given-names></name><name><surname>Demler</surname><given-names>Olga</given-names></name><name><surname>Faraone</surname><given-names>Steve</given-names></name><name><surname>Hiripi</surname><given-names>Eva</given-names></name><name><surname>Howes</surname><given-names>Mary J</given-names></name><name><surname>Jin</surname><given-names>Robert</given-names></name><name><surname>Secnik</surname><given-names>Kristina</given-names></name><name><surname>Spencer</surname><given-names>Thomas</given-names></name><name><surname>Ustun</surname><given-names>T Bedirhan</given-names></name><name><surname>Walters</surname><given-names>Ellen E</given-names></name></person-group><article-title>The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population</article-title><source>Psychol Med</source><year>2005</year><month>2</month><volume>35</volume><issue>2</issue><fpage>245</fpage><lpage>56</lpage><pub-id pub-id-type="medline">15841682</pub-id><pub-id pub-id-type="pmid">15841682</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>BJ</given-names></name><name><surname>Trainor</surname><given-names>RJ</given-names></name><name><surname>Orendi</surname><given-names>JL</given-names></name><name><surname>Schubert</surname><given-names>AB</given-names></name><name><surname>Nystrom</surname><given-names>LE</given-names></name><name><surname>Giedd</surname><given-names>JN</given-names></name><name><surname>Castellanos</surname><given-names>FX</given-names></name><name><surname>Haxby</surname><given-names>JV</given-names></name><name><surname>Noll</surname><given-names>DC</given-names></name><name><surname>Cohen</surname><given-names>JD</given-names></name><name><surname>Forman</surname><given-names>SD</given-names></name><name><surname>Dahl</surname><given-names>RE</given-names></name><name><surname>Rapoport</surname><given-names>JL</given-names></name></person-group><article-title>A Developmental Functional MRI Study of Prefrontal Activation during Performance of a Go-No-Go Task</article-title><source>J Cogn Neurosci</source><year>1997</year><month>11</month><volume>9</volume><issue>6</issue><fpage>835</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1162/jocn.1997.9.6.835</pub-id><pub-id pub-id-type="medline">23964603</pub-id><pub-id pub-id-type="pmid">23964603</pub-id></element-citation></ref></ref-list></back></article>